RAVmed unit Lucid Diagnostics files IPO plan
Lucid is focused on patients with gastroesophageal reflux disease, also known as chronic heartburn or acid reflux, who are at risk of developing esophageal cancer.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: I-Chun Chen Source Type: news
More News: Acid Reflux | Cancer | Cancer & Oncology | Esophagus Cancer | Gastroenterology | Gastroesophageal Reflux Disease | GERD | Health Management | Heartburn | Pharmaceuticals